IGLVIV-66-1

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, IGLVIV-66-1 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated IGLVIV-66-1 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher IGLVIV-66-1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated IGLVIV-66-1 expression acts as an unfavorable survival marker, although some lineages such as SKCM and HNSC show a favorable association.

LUSC, OV, and BLCA are the cancer types where IGLVIV-66-1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
LUSCOSTertileIII,IV0.3410.601.01545view →
OVOSTertileIV0.0220.760<.00136view →
BLCADFSTertileIV0.1090.481<.00136view →
SKCMOSTertileAll1.0000.848.01027view →
GBMOSTertileAll0.1030.415.00318view →
DLBCOSTertileAll0.0530.936<.00118view →
COADOSTertileIII,IV0.1910.701.03818view →
PRADOSTertileAll0.9060.990<.00118view →
THCADFSTertileAll0.7210.921.0119view →
READOSTertileAll0.5350.909.0049view →
THYMOSTertileAll0.8080.971.0356view →
UCECOSTertileIII,IV0.6680.837.0486view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

IGLVIV-66-1–LUSC (OS)

Kaplan–Meier survival curve for IGLVIV-66-1 RNA-high vs -low samples in LUSC.

Open the LUSC breakdown →

Exploration